Article ID Journal Published Year Pages File Type
10101396 The American Journal of Surgery 2005 4 Pages PDF
Abstract
The use of factor VIIa in patients with life-threatening hemorrhage is a safe and effective therapeutic modality when used as an adjunct to standard interventions for control of severe hemorrhage. Lower-dose regimens were as successful as higher-dose regimens previously reported. The results of this respective study of 13 patients suggests that recombinant factor VIIa therapy for control of life-threatening hemorrhage as an adjunct to standard interventions can be successful at doses <90 mg/kg.
Related Topics
Health Sciences Medicine and Dentistry Surgery
Authors
, , , , , , ,